Picture of Chimerix logo

CMRX — Chimerix News Story

0.000.00%
us flag iconLast trade - 00:00
HealthcareSpeculativeMid CapMomentum Trap

Chimerix Inc expected to post a loss of 23 cents a share - Earnings Preview

* Chimerix Inc  CMRX.OQ   CMRX.O  is expected to show a fall
in
quarterly revenue when it reports  results 
    * The Durham North Carolina-based  company is expected to
report 
a 99.8% decrease in revenue to $76.43 thousand from $32.56
million a year ago, according to the mean estimate from 7
analysts, based on Refinitiv data. 
    * ​Refinitiv's mean analyst estimate for Chimerix Inc is for
a
loss of 23 cents per share. 
    * The current average analyst rating on the shares is "buy"
and
the breakdown of recommendations is 7 "strong buy" or "buy," no
"hold" and no "sell" or "strong sell."  
    * The mean earnings estimate of analysts was unchanged in
the last
three months. ​
    * Wall Street's median 12-month price target for Chimerix
Inc is
$7​, above​ its last closing price of $0.96. ​​​

Previous quarterly performance (using preferred earnings measure
in US dollars). ​
 QUARTER       STARMINESM  REFINITIV  ACTUAL    BEAT,   SURPRI
 ENDING        ARTESTIMAT  IBES                 MET,    SE %
               E®          ESTIMATE             MISSED  
 Jun. 30 2023  -0.23       -0.24      -0.21     Beat    13.8
 Mar. 31 2023  -0.25       -0.25      -0.24     Beat    4.1
 Dec. 31 2022  -0.24       -0.24      -0.24     Met     -1.4​
 Sep. 30 2022  2.13        2.14       2.75      Beat    28.6
 ​​Jun.        -0.25       -0.24      -0.27     Missed  -11.6
 30 2022                                                
 Mar. 31 2022  -0.33       -0.33      -0.28     Beat    15.6​
 Dec. 31 2021  -0.32       -0.17      -0.45     Missed  -157.1
 Sep. 30 2021  -0.14       -0.15      -0.21     Missed  -40.6
 This summary was machine generated October 31 at 18:55 GMT.  All
figures in US dollars  unless otherwise stated

Recent news on Chimerix

See all news